Cargando…
KCNQ1OT1 contributes to sorafenib resistance and programmed death-ligand-1-mediated immune escape via sponging miR-506 in hepatocellular carcinoma cells
Drug resistance and immune escape of tumor cells severely compromise the treatment efficiency of hepatocellular carcinoma (HCC). Long non-coding RNA KCNQ1 overlapping transcript 1 (lncRNA KCNQ1OT1) has been shown to be involved in drug resistance in several cancers. The aim of the present study was...
Autores principales: | Zhang, Junli, Zhao, Xiaohui, Ma, Xiaojuan, Yuan, Zengyan, Hu, Miao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521583/ https://www.ncbi.nlm.nih.gov/pubmed/33000204 http://dx.doi.org/10.3892/ijmm.2020.4710 |
Ejemplares similares
-
KCNQ1OT1 polymorphism rs35622507 and methylation status of KCNQ1OT1 promoter influence the drug resistance to L-OHP
por: Zhang, Caihong, et al.
Publicado: (2022) -
KCNQ1OT1 promotes melanoma growth and metastasis
por: Guo, Bingyu, et al.
Publicado: (2018) -
KCNQ1OT1: An Oncogenic Long Noncoding RNA
por: Cagle, Patrice, et al.
Publicado: (2021) -
Regulation of functional KCNQ1OT1 lncRNA by β-catenin
por: Sunamura, Naohiro, et al.
Publicado: (2016) -
LncRNA KCNQ1OT1 sponges miR-34c-5p to promote osteosarcoma growth via ALDOA enhanced aerobic glycolysis
por: Shen, Yifei, et al.
Publicado: (2020)